Literature DB >> 22166417

Neurorestoration by physical exercise: moving forward.

Michael J Zigmond1, Judy L Cameron, Barry J Hoffer, Richard J Smeyne.   

Abstract

Although a good deal is known about the pathophysiology of Parkinson's disease and information is emerging about its cause, there are no pharmacological treatments shown to have a significant, sustained capacity to prevent or attenuate the condition. However, accumulating clinical evidence suggests that physical exercise can provide this much needed treatment, and studies of animal models of the dopamine deficiency associated with the motor symptoms of Parkinson's disease further support this hypothesis. Thus, in our collaborative research efforts, we seek to understand the biological basis for exercise-induced protection in order to assist in the development of a safe and clinically effective intervention based on increased physical activity. In addition, we recognize that some individuals cannot or will not engage in physical exercise, and believe that mechanistic studies of exercise-induced protection will provide insights into the development of drugs that could emulate its effects. Using toxins that induce a deficiency of dopamine, we have affirmed that physical exercise can reduce behavioral and neurobiological deficits induced by such toxins, and suggest that these neuroprotective effects are likely to involve the activation of signaling cascades by neurotrophic factors such as glial cell line derived neurotrophic factor.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22166417     DOI: 10.1016/S1353-8020(11)70046-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  20 in total

Review 1.  Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.

Authors:  Jing-Huei Lai; Kai-Yun Chen; John Chung-Che Wu; Lars Olson; Stefan Brené; Chi-Zong Huang; Yen-Hua Chen; Shuo-Jhen Kang; Kuo-Hsing Ma; Barry J Hoffer; Tsung-Hsun Hsieh; Yung-Hsiao Chiang
Journal:  Brain Res       Date:  2019-06-18       Impact factor: 3.252

Review 2.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

Review 3.  Roles of myokines in exercise-induced improvement of neuropsychiatric function.

Authors:  Sujin Kim; Ji-Young Choi; Sohee Moon; Dong-Ho Park; Hyo-Bum Kwak; Ju-Hee Kang
Journal:  Pflugers Arch       Date:  2019-01-09       Impact factor: 3.657

4.  Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease.

Authors:  Neil A Kelly; Matthew P Ford; David G Standaert; Ray L Watts; C Scott Bickel; Douglas R Moellering; S Craig Tuggle; Jeri Y Williams; Laura Lieb; Samuel T Windham; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

Review 5.  Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex.

Authors:  Tonghui Xu; Shaofang Wang; Rupa R Lalchandani; Jun B Ding
Journal:  Mov Disord       Date:  2017-03-25       Impact factor: 10.338

6.  A pilot study to evaluate multi-dimensional effects of dance for people with Parkinson's disease.

Authors:  Maria I Ventura; Deborah E Barnes; Jessica M Ross; Kimberly E Lanni; Karen A Sigvardt; Elizabeth A Disbrow
Journal:  Contemp Clin Trials       Date:  2016-10-17       Impact factor: 2.226

7.  Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans.

Authors:  Charity G Moore; Margaret Schenkman; Wendy M Kohrt; Anthony Delitto; Deborah A Hall; Daniel Corcos
Journal:  Contemp Clin Trials       Date:  2013-06-14       Impact factor: 2.226

8.  Getting to compliance in forced exercise in rodents: a critical standard to evaluate exercise impact in aging-related disorders and disease.

Authors:  Jennifer C Arnold; Michael F Salvatore
Journal:  J Vis Exp       Date:  2014-08-22       Impact factor: 1.355

9.  Initial treatment of Parkinson's disease: an update.

Authors:  Scott Kaplan; Daniel Tarsy
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 10.  Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.

Authors:  Francesca L'Episcopo; Cataldo Tirolo; Salvo Caniglia; Nuccio Testa; Maria Concetta Morale; Maria Francesca Serapide; Stefano Pluchino; Bianca Marchetti
Journal:  J Mol Cell Biol       Date:  2014-01-14       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.